MSA
SCLN

Mason Street Advisors’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Mason Street Advisors’s Portfolio SCLN Stock Details SCLN Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
2017
Q3 		$148K Buy
2017
Q2 		$140K Buy
2017
Q1 		$118K Buy
2016
Q4 		$120K Buy
2016
Q3 		$105K Buy
2016
Q2 		$127K Buy